Suppr超能文献

需要透析的肾病患者中韦格纳肉芽肿病的长期预后。

Longterm outcome of Wegener's granulomatosis in patients with renal disease requiring dialysis.

作者信息

Mekhail T M, Hoffman G S

机构信息

Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Ohio, USA.

出版信息

J Rheumatol. 2000 May;27(5):1237-40.

Abstract

OBJECTIVE

It is known that renal failure is a poor prognostic marker for survival in Wegener's granulomatosis (WG). We investigated the longterm outcome of patients with WG who have severe renal disease requiring dialysis.

METHODS

We performed a retrospective analysis of 104 patients with WG followed at our institution between 1982 and 1997. Twenty-three patients who required dialysis were studied in detail to determine outcomes and factors that influenced survival and restoration of renal function.

RESULTS

Of 23 dialysis dependent patients with WG, 11 died (Group 1). 7 either remained dialysis dependent or received successful renal transplants (Group 2), and 5 substantially recovered renal function (Group 3). Mean serum creatinine at the end of a mean followup period of 38.4 months for Group 3 was 1.8 mg/dl. There was no apparent difference between groups in regard to disease profile, e.g., distribution of organ involvement or serum creatinine when renal impairment was first recognized (mean serum creatinine for groups: 1: 3.0 mg/dl; 2: 5.6 mg/dl; 3: 5.5 mg/dl) and peak serum creatinine prior to dialysis (means for groups: 1: 9.5 mg/dl; 2: 10.5 mg/dl; 3: 9.6 mg/dl). Infection secondary to immunosuppression was the leading cause of death in Group I patients.

CONCLUSION

Because the clinical profile and degree of renal failure, as judged by serum creatinine, did not differ among patients who did or did not regain dialysis independent renal function, we recommend aggressive immunosuppressive therapy in all cases of active WG with acute rapidly worsening renal failure, regardless of the severity of renal impairment.

摘要

目的

已知肾衰竭是韦格纳肉芽肿(WG)患者生存的不良预后指标。我们调查了患有严重肾脏疾病需要透析的WG患者的长期预后。

方法

我们对1982年至1997年间在我院随访的104例WG患者进行了回顾性分析。对23例需要透析的患者进行了详细研究,以确定其预后以及影响生存和肾功能恢复的因素。

结果

23例依赖透析的WG患者中,11例死亡(第1组)。7例要么继续依赖透析,要么接受了成功的肾移植(第2组),5例肾功能基本恢复(第3组)。第3组在平均38.4个月的随访期末,平均血清肌酐为1.8mg/dl。在疾病特征方面,如器官受累分布或首次发现肾功能损害时的血清肌酐水平(各组平均血清肌酐:第1组:3.0mg/dl;第2组:5.6mg/dl;第3组:5.5mg/dl)以及透析前血清肌酐峰值(各组平均值:第1组:9.5mg/dl;第2组:10.5mg/dl;第3组:9.6mg/dl),各组之间无明显差异。免疫抑制继发感染是第1组患者的主要死亡原因。

结论

由于根据血清肌酐判断,恢复或未恢复非透析依赖肾功能的患者的临床特征和肾衰竭程度无差异,因此我们建议,对于所有急性快速进展性肾衰竭的活动性WG患者,无论肾功能损害的严重程度如何,均应积极进行免疫抑制治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验